X4 Pharmaceuticals, Inc. · NASDAQ:XFOR

Kirske David sold 8,543 X4 Pharmaceuticals, Inc. shares (Form 4)

Traded Jun 30, 2026 · Filed Jul 1, 2026

On Jun 30, 2026, Kirske David (Chief Financial Officer) sold 8,543 X4 Pharmaceuticals, Inc. shares at US$4.26 for US$36,393, leaving 167,750 shares. Filed Jul 1, 2026 (Form 4).

Sold
8,543 shares
Price
US$4.26
Value
US$36,393
Holding after
167,750 shares
Trading plan
No
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 30, 2026Common StockSale8,543US$4.26167,750Direct

Source

View original at SEC

Related